Susquehanna Fundamental Investments, LLC Oncternal Therapeutics, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$4.75 - $9.39 $202,834 - $400,971	-42,702 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.59 - $9.04 $140,922 - $277,546	30,702 Added 255.85%	42,702 $355,000
Q4 2020 Feb 16, 2021	BUY	$1.51 - $6.3 $18,120 - $75,600	12,000 New	12,000 $59,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.